Latest filing published 07 Aug 2026 for Jazz Pharmaceuticals plc, €177k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Samantha Pearce is a declared insider of Jazz Pharmaceuticals plc (senior executive), with filings sourced from SEC (Form 4). Between 3 March 2022 and 5 August 2026, the trades on record add up to 23 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 7 August 2026, reports a share grant of €177k in Jazz Pharmaceuticals plc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations